drugset / Trial / NCT04806347

Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults

NCT04806347 ↗

Phase 1 Not yet recruiting 12 enrolled University of Wisconsin, Madison
NaSingle-groupOpen-labelTreatment

Summary

This study is being done to see if the investigators can take peripheral blood stem cells from either an adult family member or a closely matched unrelated donor, and run them through a special lab instrument to remove alpha/beta T cells and B cells and then give them to the patient to treat disease. This is an experimental way of doing a hematopoietic stem cell transplant (HSCT). The investigators want to see if the new stem cells will grow without bad graft vs. host disease (GVHD). This treatment approach is experimental in the United States.

Timeline

Start
2026-07
Primary completion
2029-05
Completion
2030-05

Drugs

EvaluationDrugModalityDoseRoute
Subject TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft Cell therapy — Intravenous

Indications